IMC Chicago
CLVS

IMC Chicago’s Clovis Oncology, Inc. CLVS Stock Holding History

IMC Chicago’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-105,300
Closed -$285K – 1305
2021
Q4 		$285K Buy
105,300
+1,400
+1% +$5.17K ﹤0.01% 1153
2021
Q3 		$463K Buy
+103,900
New +$500K ﹤0.01% 1116
2021
Q2 		– Sell
-148,400
Closed -$1.04M – 1213
2021
Q1 		$1.04M Buy
+148,400
New +$995K ﹤0.01% 849
2020
Q4 		– Sell
-216,500
Closed -$1.26M – 1123
2020
Q3 		$1.26M Buy
216,500
+117,900
+120% +$705K ﹤0.01% 681
2020
Q2 		$666K Buy
+98,600
New +$747K ﹤0.01% 769

Other funds holding CLVS

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return